-transparent.png){kind=logo}
OBJECTIVE To compare serum ferritin concentration and transferrin saturation in patients with alcoholic and non-alcoholic chronic liver diseases. METHODS Consecutive patients with liver diseases. METHODS The department of internal medicine in a teaching hospital. METHODS Three hundred and twelve patients with different liver diseases consecutively admitted between 1987 and 1992. METHODS None. METHODS Fasting serum iron, transferrin and ferritin. RESULTS Serum ferritin was increased above 200 micrograms L-1 in all 18 patients with haemochromatosis (range 310-6500 micrograms L-1), in 64 of 111 alcoholics (58%) and in 30 of 137 (22%) with chronic non-alcoholic liver diseases (P < 0.01). Twelve of 111 alcoholics (11%) had serum ferritin above 1000 micrograms L-1 compared with one of 137 (0.7%) with chronic non-alcoholic liver diseases. In 13 alcoholics who abstained after admission, serum ferritin decreased from 1483 micrograms L1 +/- 1134 to 388 micrograms L-1 +/- 237 (P < 0.001) after 1 1/2 to 6 weeks. The transferrin saturation was increased above 62% in 13 of 18 patients (72%) with haemochromatosis, in 16 of 105 alcoholics (15.2%) and in three of 132 (2.3%) with chronic non-alcoholic liver disease (P < 0.01). CONCLUSIONS Serum ferritin is more frequently elevated in abusing patients with alcoholic liver disease than in patients with other chronic liver diseases such as autoimmune liver diseases and hepatitis C. Because serum ferritin decreases rapidly during abstinence, the measurement of ferritin for the detection of haemochromatosis in patients abusing alcohol should be postponed until the patients are abstaining. Most of the patients with increased serum ferritin have normal transferrin saturation values which can be used to separate them from haemochromatosis.
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
January 1987,
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
June 2020,
Biological trace element research,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
November 2004,
Gastroenterologia y hepatologia,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
April 2011,
Genetics and molecular research : GMR,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
May 2004,
Journal of the National Medical Association,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
June 1991,
Orvosi hetilap,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
April 2007,
Archives of internal medicine,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
September 2006,
Clinical journal of the American Society of Nephrology : CJASN,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
January 1968,
Blut,
H Bell, and
A Skinningsrud, and
N Raknerud, and
K Try
March 1975,
Gastroenterology,
